News By Tag
News By Location
SBH Science Announces the Implementation of Novel Immunoassay Testing Platform
CyVek, Inc. and SBH Sciences have initiated their collaboration with the first placement of the CyPlex™ System in the United States
Dr. Raphael Nir, President and Chief Science Officer, SBH Sciences, said, “We are excited and proud to be the first CRO to add this innovative analytical tool to our services list. We are routinely using Luminex and it would be interesting to compare the 10-plus year platform with the most advanced multi-analyte bench top immunoassay system. It is our strategy to offer the most advanced service to the biotech industry. Since we are among the world experts in cytokine research, and are welcoming new collaborative research studies, this new tool will substantially increase our capabilities.”
Bill Dubiel, Chief Commercial Officer, CyVek, Inc., said, “From our first meeting with SBH Sciences, Dr. Nir clearly saw how this new technology might help his business model. We are excited to work together with SBH Sciences’ CLIA-certified facility to move the CyPlex™ system to the next level of testing."
CyPlex’s ability to provide “sample-to-
About SBH Sciences: SBH Sciences is an innovative pre-clinical contract research organization, located in Natick, Massachusetts. SBH Science's unique assays and customized biological products enhance discovery and bio-pharmaceutical development in oncology and inflammation research. SBH Sciences has been chosen by over 120 biotechnology and pharmaceutical companies for their service needs since 1997. SBH Sciences is also the leader of a network of specialized technology partners (http://sbhsciences.com/
About CyVek: CyVek is a privately funded biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology, CyPlexTM, for performing multi-analyte immunoassays. For more information about CyVek, please call 203-679-0395 or visit us on the web at: www.cyplexsystems.com.